Compare Divis Laboratories with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs ABBOTT INDIA - Comparison Results

DIVIS LABORATORIES     Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES ABBOTT INDIA DIVIS LABORATORIES/
ABBOTT INDIA
 
P/E (TTM) x 32.4 43.1 75.1% View Chart
P/BV x 7.3 12.4 59.1% View Chart
Dividend Yield % 0.6 0.6 109.9%  

Financials

 DIVIS LABORATORIES   ABBOTT INDIA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-18
ABBOTT INDIA
Mar-18
DIVIS LABORATORIES/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,1426,110 18.7%   
Low Rs5333,996 13.3%   
Sales per share (Unadj.) Rs146.61,552.2 9.4%  
Earnings per share (Unadj.) Rs33.0188.8 17.5%  
Cash flow per share (Unadj.) Rs38.4196.4 19.6%  
Dividends per share (Unadj.) Rs10.0055.00 18.2%  
Dividend yield (eoy) %1.21.1 109.7%  
Book value per share (Unadj.) Rs222.8796.6 28.0%  
Shares outstanding (eoy) m265.4721.25 1,249.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.73.3 175.5%   
Avg P/E ratio x25.326.8 94.7%  
P/CF ratio (eoy) x21.825.7 84.8%  
Price / Book Value ratio x3.86.3 59.2%  
Dividend payout %30.329.1 103.9%   
Avg Mkt Cap Rs m222,318107,376 207.0%   
No. of employees `00010.83.3 324.0%   
Total wages/salary Rs m4,5613,937 115.8%   
Avg. sales/employee Rs Th3,616.09,929.3 36.4%   
Avg. wages/employee Rs Th423.81,185.1 35.8%   
Avg. net profit/employee Rs Th814.91,207.7 67.5%   
INCOME DATA
Net Sales Rs m38,91532,985 118.0%  
Other income Rs m1,1341,170 97.0%   
Total revenues Rs m40,04934,155 117.3%   
Gross profit Rs m12,6175,245 240.6%  
Depreciation Rs m1,425162 880.1%   
Interest Rs m1338 34.8%   
Profit before tax Rs m12,3136,215 198.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,5432,203 160.9%   
Profit after tax Rs m8,7704,012 218.6%  
Gross profit margin %32.415.9 203.9%  
Effective tax rate %28.835.4 81.2%   
Net profit margin %22.512.2 185.3%  
BALANCE SHEET DATA
Current assets Rs m45,35122,655 200.2%   
Current liabilities Rs m6,5076,681 97.4%   
Net working cap to sales %99.848.4 206.1%  
Current ratio x7.03.4 205.5%  
Inventory Days Days12765 195.6%  
Debtors Days Days9529 326.4%  
Net fixed assets Rs m21,160835 2,532.6%   
Share capital Rs m531213 249.8%   
"Free" reserves Rs m58,62516,715 350.7%   
Net worth Rs m59,15616,928 349.5%   
Long term debt Rs m00-   
Total assets Rs m67,83224,162 280.7%  
Interest coverage x926.8163.7 566.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.4 42.0%   
Return on assets %12.916.8 77.2%  
Return on equity %14.823.7 62.6%  
Return on capital %20.836.9 56.4%  
Exports to sales %00-   
Imports to sales %21.80-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m8,485NA-   
Fx inflow Rs m32,359369 8,780.3%   
Fx outflow Rs m9,0423,807 237.5%   
Net fx Rs m23,317-3,438 -678.2%   
CASH FLOW
From Operations Rs m7,7591,527 508.1%  
From Investments Rs m-4,783-2,148 222.6%  
From Financial Activity Rs m-3,142-1,024 306.7%  
Net Cashflow Rs m-166-1,646 10.1%  

Share Holding

Indian Promoters % 52.0 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 11.8 7.9 149.4%  
FIIs % 19.0 0.1 19,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 17.1 100.6%  
Shareholders   31,796 18,270 174.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   BIOCON   WOCKHARDT  AUROBINDO PHARMA  PLETHICO PHARMA  FDC LTD.  

Compare DIVIS LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Strengthening Rupee, Inflation & Factory Output Data, and Top Stocks in Action Today(Pre-Open)

On Friday, Indian share markets witnessed most of the buying interest during closing hours and ended on a strong note.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Sep 13, 2019 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS